rs147405081

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_181486.4(TBX5):​c.787G>A​(p.Val263Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000882 in 1,614,004 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00057 ( 6 hom. )

Consequence

TBX5
NM_181486.4 missense

Scores

2
4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.57
Variant links:
Genes affected
TBX5 (HGNC:11604): (T-box transcription factor 5) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010288835).
BP6
Variant 12-114366360-C-T is Benign according to our data. Variant chr12-114366360-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 198693.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-114366360-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00392 (597/152124) while in subpopulation AFR AF= 0.0125 (519/41522). AF 95% confidence interval is 0.0116. There are 4 homozygotes in gnomad4. There are 301 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 597 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBX5NM_181486.4 linkuse as main transcriptc.787G>A p.Val263Met missense_variant 8/9 ENST00000405440.7 NP_852259.1
TBX5NM_000192.3 linkuse as main transcriptc.787G>A p.Val263Met missense_variant 8/9 NP_000183.2
TBX5NM_080717.4 linkuse as main transcriptc.637G>A p.Val213Met missense_variant 7/8 NP_542448.1
TBX5XM_017019912.2 linkuse as main transcriptc.835G>A p.Val279Met missense_variant 8/9 XP_016875401.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBX5ENST00000405440.7 linkuse as main transcriptc.787G>A p.Val263Met missense_variant 8/91 NM_181486.4 ENSP00000384152 P1Q99593-1
TBX5ENST00000310346.8 linkuse as main transcriptc.787G>A p.Val263Met missense_variant 8/91 ENSP00000309913 P1Q99593-1
TBX5ENST00000349716.9 linkuse as main transcriptc.637G>A p.Val213Met missense_variant 7/81 ENSP00000337723 Q99593-3
TBX5ENST00000526441.1 linkuse as main transcriptc.787G>A p.Val263Met missense_variant 7/71 ENSP00000433292 Q99593-2

Frequencies

GnomAD3 genomes
AF:
0.00389
AC:
591
AN:
152006
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00387
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00240
GnomAD3 exomes
AF:
0.00122
AC:
307
AN:
251214
Hom.:
0
AF XY:
0.000987
AC XY:
134
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000565
AC:
826
AN:
1461880
Hom.:
6
Cov.:
32
AF XY:
0.000507
AC XY:
369
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.0125
Gnomad4 AMR exome
AF:
0.00221
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000812
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000194
Gnomad4 OTH exome
AF:
0.00106
GnomAD4 genome
AF:
0.00392
AC:
597
AN:
152124
Hom.:
4
Cov.:
32
AF XY:
0.00405
AC XY:
301
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0125
Gnomad4 AMR
AF:
0.00386
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000191
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.000710
Hom.:
0
Bravo
AF:
0.00425
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0116
AC:
51
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00128
AC:
155
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 21, 2018- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 15, 2018Variant summary: The TBX5 c.787G>A (p.Val263Met) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). Though a recent functional study demonstrated that the variant of interest could disrupts the TBX5-NuRD interaction (Waldron 2016), another study provided evidence that TBX5 activity may be extensively regulated through alternative splicing where the variant of interest would not affect isoforms lacking exon 9 (Yamak 2015). This variant was found in 403/276910 control chromosomes (with 1 homozygous occurrence), predominantly observed in the African subpopulation at a frequency of 0.012288 (295/24008). This frequency is about 2809 times the estimated maximal expected allele frequency of a pathogenic TBX5 variant (0.0000044), strong evidence that this is a benign polymorphism. The variant was reported in the literature in affected individuals, however without strong evidence for causality (Faria 2008, Bonachea 2014), i.e. no clear co-segregation could be demonstrated. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Taken together, this variant is classified as benign. -
Holt-Oram syndrome Benign:2
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsApr 17, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 19, 2020This variant is associated with the following publications: (PMID: 18706711, 25260786) -
Aortic valve disease 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 01, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.31
.;T;T;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D;.;D;D
MetaRNN
Benign
0.010
T;T;T;T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
1.8
.;L;L;L
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
-0.47
N;N;N;N
REVEL
Benign
0.27
Sift
Benign
0.40
T;T;T;T
Sift4G
Benign
0.22
T;T;T;T
Polyphen
0.99, 0.58
.;D;D;P
Vest4
0.77
MVP
0.76
MPC
1.7
ClinPred
0.038
T
GERP RS
5.6
Varity_R
0.091
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147405081; hg19: chr12-114804165; API